{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004230195458048.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/jps.22631"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022354915319675?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022354915319675?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"21590775"}},{"identifier":{"@type":"NAID","@value":"20000763204"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"6-Mercaptopurine Transport by Equilibrative Nucleoside Transporters in Conditionally Immortalized Rat Syncytiotrophoblast Cell Lines TR-TBTs"}],"description":[{"notation":[{"@value":"Recently, more women were provided with 6-mercaptopurine (6-MP) during pregnancy. Therefore, we attempted to clarify the transport mechanisms of 6-MP through blood-placenta barrier using rat conditionally immortalized syncytiotrophoblast cell lines (TR-TBTs). The uptake of 6-MP was time- and ATP dependent, but sodium independent in TR-TBTs. 6-MP was eliminated over 50% from the cells within 30 min. The uptake of 6-MP was saturable with Michaelis-Menten constant values of 198 μM and 250 μM in TR-TBT 18d-1 and TR-TBT 18d-2, respectively. 6-Thioguanine, azathioprine, and hypoxantine, structural analogues of 6-MP, strongly inhibited [(14) C]6-MP uptake. Equilibrative nucleoside transporter (ENT) inhibitors, adenosine and uridine, significantly inhibited [(14) C]6-MP uptake. However, several organic anions and cations had no effect on [(14) C]6-MP uptake in TR-TBTs. These results suggest that sodium-independent transporters, ENTs, may be involved in 6-MP uptake at the placenta. In addition, multidrug resistance protein (MRP) inhibitors, methotrexate, probenecid, cefmetazole, and sulfinpyrazone, significantly increased the accumulation of [(14) C]6-MP in the cells. It is indicated that 6-MP may be eliminated across the blood-placental barrier via MRPs. TR-TBTs expressed mRNA of ENT1, ENT2, MRP4, and MRP5. These findings are important for the therapy of acute lymphoblastic leukemia and autoimmune diseases of pregnant women, and should be useful data in elucidating teratogenicity of 6-MP during pregnancy."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004230195458052","@type":"Researcher","foaf:name":[{"@value":"Na-young Lee"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326220214912","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"40262589"},{"@type":"NRID","@value":"1000040262589"},{"@type":"NRID","@value":"9000409576500"},{"@type":"NRID","@value":"9000006688097"},{"@type":"NRID","@value":"9000005277062"},{"@type":"NRID","@value":"9000391913903"},{"@type":"NRID","@value":"9000258574071"},{"@type":"NRID","@value":"9000254235157"},{"@type":"NRID","@value":"9000006192881"},{"@type":"NRID","@value":"9000415224098"},{"@type":"NRID","@value":"9000007007249"},{"@type":"NRID","@value":"9000315146867"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0187749"}],"foaf:name":[{"@value":"Yoshimichi Sai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004230195458048","@type":"Researcher","foaf:name":[{"@value":"Emi Nakashima"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004230195458051","@type":"Researcher","foaf:name":[{"@value":"Sumio Ohtsuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004230195458050","@type":"Researcher","foaf:name":[{"@value":"Young-sook Kang"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00223549"}],"prism:publicationName":[{"@value":"Journal of Pharmaceutical Sciences"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-09","prism:volume":"100","prism:number":"9","prism:startingPage":"3773","prism:endingPage":"3782"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022354915319675?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022354915319675?httpAccept=text/plain"}],"createdAt":"2011-05-17","modifiedAt":"2020-06-19","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Antimetabolites,%20Antineoplastic","dc:title":"Antimetabolites, Antineoplastic"},{"@id":"https://cir.nii.ac.jp/all?q=Base%20Sequence","dc:title":"Base Sequence"},{"@id":"https://cir.nii.ac.jp/all?q=Mercaptopurine","dc:title":"Mercaptopurine"},{"@id":"https://cir.nii.ac.jp/all?q=Animals","dc:title":"Animals"},{"@id":"https://cir.nii.ac.jp/all?q=Carrier%20Proteins","dc:title":"Carrier Proteins"},{"@id":"https://cir.nii.ac.jp/all?q=Cell%20Line,%20Transformed","dc:title":"Cell Line, Transformed"},{"@id":"https://cir.nii.ac.jp/all?q=DNA%20Primers","dc:title":"DNA Primers"},{"@id":"https://cir.nii.ac.jp/all?q=Rats","dc:title":"Rats"},{"@id":"https://cir.nii.ac.jp/all?q=Trophoblasts","dc:title":"Trophoblasts"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782047272960","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"20590158"},{"@type":"JGN","@value":"JP20590158"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20590158/"}],"notation":[{"@language":"ja","@value":"胎盤関門のダイナミクスを制御するトランスポーター-エズリン複合体"},{"@language":"en","@value":"Regulatory role of ezrin on transportsome at the blood placenta barrier"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257060298752","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21590175"},{"@type":"JGN","@value":"JP21590175"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21590175/"}],"notation":[{"@language":"ja","@value":"血液-組織関門を形成する細胞群のヒト細胞株の樹立と低用量抗がん薬の作用機序解明"},{"@language":"en","@value":"Establishment of human cell lines for blood-tissue barrier and application to elucidate mechanism of low-dose anti-cancer drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257141783808","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23590173"},{"@type":"JGN","@value":"JP23590173"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23590173/"}],"notation":[{"@language":"ja","@value":"副作用マネジメントと毒性回避のための臨床薬物動態研究"},{"@language":"en","@value":"Clinical pharmacokinetic study for management of drug side effects"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011144567960064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Functional and Molecular Characterization of Nucleobase Transport by Recombinant Human and Rat Equilibrative Nucleoside Transporters 1 and 2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145138114304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619559294464","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of members of the multidrug resistance protein family in human term placenta"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621195771136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Kinetic and Pharmacological Properties of Cloned Human Equilibrative Nucleoside Transporters, ENT1 and ENT2, Stably Expressed in Nucleoside Transporter-deficient PK15 Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095939266176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Presence of Xenobiotic Transporters in Rat Placenta"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570550521600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Organic anion transporter 3 is involved in the brain‐to‐blood efflux transport of thiopurine nucleobase analogs"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044159775872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Influx Mechanism of 2′,3′-Dideoxyinosine and Uridine at the Blood–Placenta Barrier"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044360504064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046029201280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519955480832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta)"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699993760146432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468523000064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Basal Membrane Localization of MRP1 in Human Placental Trophoblast"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468581413248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Potential of Various Drugs to Inhibit Nucleoside Uptake in Rat Syncytiotrophoblast Cell Line, TR-TBT 18d-1"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946442593536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cellular Export of Drugs and Signaling Molecules by the ATP-binding Cassette Transporters MRP4 (ABCC4) and MRP5 (ABCC5)"}]},{"@id":"https://cir.nii.ac.jp/crid/1362541648444297472","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418753765120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893630118912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR‐TBTs"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893854346880","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894482445696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Therapeutic Drug Use in Women With Crohn's Disease and Birth Outcomes: A Danish Nationwide Cohort Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895884808192","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Choline Transport via Choline Transporter-like Protein 1 in Conditionally Immortalized Rat Syncytiotrophoblast Cell Lines TR-TBT"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107371376912896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression, Localization, and Function of MRP5 (ABCC5), a Transporter for Cyclic Nucleotides, in Human Placenta and Cultured Human Trophoblasts"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319636609920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characterization of the Mechanism of Zidovudine Uptake by Rat Conditionally Immortalized Syncytiotrophoblast Cell Line TR-TBT"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320529227904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunosuppression during pregnancy: Transmission of azathioprine and its metabolites from the mother to the fetus"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794609510400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Inhibitory Effect of Rivastigmine and Galantamine on Choline Transport in Brain Capillary Endothelial Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795473921024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cancer in older persons. Magnitude of the problem-how do we apply what we know?"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796060209024","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269146597504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Thiopurine Metabolism and Identification of the Thiopurine Metabolites Transported by MRP4 and MRP5 Overexpressed in Human Embryonic Kidney Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270791257216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Concepts in use of high-dose methotrexate therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270929791872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1370851344059541005","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Aging and reproductive potential in women"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204626682496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Differential Expression of Ezrin and CLP36 in the Two Layers of Syncytiotrophoblast in Rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204904338176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Microarray analysis of 6-mercaptopurine-induced-toxicity-related genes and microRNAs in the rat placenta"},{"@value":"Toxicomics Report : Microarray analysis of 6-mercaptopurine-induced-toxicity-related genes and microRNAs in the rat placenta"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205180472704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Tissue-specific mRNA Expression Profiles of Human ATP-binding Cassette and Solute Carrier Transporter Superfamiies"},{"@value":"Tissue-specific mRNA Expression Profiles of Human ATP-binding Cassette and Solute Carrier Transporter Superfamilies"},{"@value":"Tissue­specific mRNA expression profiles of human ATP­binding cassette and solute carrier transporter superfamilies"},{"@value":"Tissue‐specific mRNA expression profiles of human ATP‐binding cassette and solute carrier transporter superfamilies"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679605217280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Conditionally Immortalized Syncytiotrophoblast Cell Lines as New Tools for Study of the Blood-Placenta Barrier"},{"@value":"Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood‐placenta barrier"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/jps.22631"},{"@type":"CIA","@value":"20000763204"},{"@type":"KAKEN","@value":"PRODUCT-12277858"},{"@type":"KAKEN","@value":"PRODUCT-12890180"},{"@type":"KAKEN","@value":"PRODUCT-14127088"},{"@type":"OPENAIRE","@value":"doi_dedup___::51317b89572b0cb3a6cbaa6c14966d4f"},{"@type":"CROSSREF","@value":"10.1016/j.dmpk.2018.08.007_references_DOI_6UVGnSKxlYlyoq6PdEPlwexIrKC"}]}